Materias dentro de su búsqueda.
Mostrando 2,221 - 2,240 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.81s Limitar resultados
  1. 2221
    “…OBJECTIVE: Better knowledge of hepatitis C virus (HCV) seroprevalence at the national level can help to implement pertinent strategies to address the HCV-related burden. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis
  2. 2222
    “…Our objective was to characterize the distribution, diversity and patterns of hepatitis C virus (HCV) genotypes in the Middle East and North Africa (MENA). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns
  3. 2223
    “…AIM: Simultaneous inhibition of hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) may enhance anti-HCV effects and reduce resistance and side effects. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies
  4. 2224
    “…Intravenous illicit drug use (IDU) and hepatitis C infection (HCV) commonly co-occur among HIV-infected individuals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty
  5. 2225
    “…AIM: The present study was performed to determine any associations of genetic polymorphisms of Fas/FasL promoter regions, at Fas670 and Fas1377 and FasL844, with hepatitis C cirrhosis and HCC, with a focus on severity of disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
  6. 2226
    “…The hepatitis C virus (HCV) envelope glycoproteins E1 and E2 form a non-covalently linked heterodimer on the viral surface that mediates viral entry. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis
  7. 2227
    “…Prior to 1990, infection with hepatitis C virus (HCV) was mainly transmitted via pooled plasma products as a treatment for hereditary bleeding disorders. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C infection in patients with hereditary bleeding disorders: epidemiology, natural history, and management
  8. 2228
    “…BACKGROUND: Since direct-acting antivirals (DAAs) have been approved for the treatment of hepatitis C virus (HCV) infection, a small series of patients with new-onset neuropsychiatric alterations have been referred to us. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study
  9. 2229
    “…BACKGROUND: Direct acting antiviral hepatitis C virus (HCV) therapies are highly effective but costly. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets
  10. 2230
    “…A 58-year-old male, known to have hepatitis C virus (HCV), presented with intermittent headaches and left-sided sensorimotor symptoms. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Coexistent Ipsilateral Internal Carotid Artery Occlusion and Cerebral Venous Thrombosis in Hepatitis C
  11. 2231
    “…Hepatitis C-induced cholestatic hepatitis is a well-known fatal complication of postorthotropic liver transplantation and prolonged immunosuppression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatic Failure Due to Cholestatic Hepatitis C in an Immunosuppressed Patient Treated With Elbasvir and Grazeprevir
  12. 2232
    “…Patients with chronic hepatitis C may have advanced fibrosis at first evaluation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors
  13. 2233
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1151 Geographic Distances Between Patients and Providers for Hepatitis C Virus Infection Testing
  14. 2234
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1291 Sexually Transmitted Diseases Clinic Based Hepatitis C Testing and Linkage to Care
  15. 2235
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    741 Management of Hepatitis C Among Infectious Diseases Physicians: Current Practice and Opinions
  16. 2236
    “…With direct-acting antiviral therapy for hepatitis C, patients will be treated by general physicians (GPs) and will need training through continuing medical education (CME). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Training in emerging advances in chronic hepatitis C infection in Pakistan: the Teach - Pak project
  17. 2237
    “…BACKGROUND/PURPOSE: One to three per cent of the world’s population has hepatitis C virus (HCV) infection, which is not only a major cause of liver disease and cancer but also associated with an increased risk of atherosclerosis, despite an ostensibly favourable lipid profile. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
  18. 2238
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank
  19. 2239
    “…INTRODUCTION: Globally, between 64 and 103 million people are chronically infected with Hepatitis C virus (HCV), with more than 4.6 million people in the United States and is associated with more than 15.000 deaths annually. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals
  20. 2240
    “…OBJECTIVE: The study aimed to describe the evolution of the seroprevalence of hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-positive patients included in two cohorts in Taiwan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
Herramientas de búsqueda: RSS